Categories AlphaGraphs, Earnings, Technology
MU Earnings: Micron delivers stronger-than-expected Q4 results but stock dips
Micron Technology Inc. (NASDAQ: MU) Tuesday said its fourth-quarter revenues and profit increased in double-digits, aided by strong demand growth. The results also came in above the market’s projection, but the chipmaker’s stock declined in the extended trading session.
On an adjusted basis, fourth-quarter profit rose sharply to $2.42 per share from $1.08 per share a year ago. The impressive bottom-line performance reflects a 37% growth in revenues to $8.27 billion.
Unadjusted net income was $2.72 billion or $2.39 per share, compared to $988 million or $0.87 per share in the fourth quarter of 2020. Both revenues and earnings exceeded the consensus estimate.
“In fiscal 2021, we established DRAM and NAND technology leadership, drove record revenues across multiple markets, and initiated a quarterly dividend. The demand outlook for 2022 is strong, and Micron is delivering innovative solutions to our customers, fueling our long-term growth,” said Micron’s CEO Sanjay Mehrotra.
Read management/analysts’ comments on Micron’s Q4earnings
Micron’s stock closed Tuesday’s regular trading lower and continued to lose during the extended session after the announcement. In the past six months, the shares have declined 15%.
Prior Performance
_________________________________________________________________________________________________________________
Stocks you may like:
International Business Machines Corp. (IBM) Stock
_________________________________________________________________________________________________________________
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was